Krilogy Financial LLC trimmed its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 87.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,844 shares of the exchange traded fund’s stock after selling 69,973 shares during the period. Krilogy Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $1,490,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Axiom Investment Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $26,000. Financial Life Planners purchased a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $27,000. Angeles Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $28,000. SHP Wealth Management acquired a new position in SPDR S&P Biotech ETF during the fourth quarter worth $31,000. Finally, Morling Financial Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the second quarter worth $36,000.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA:XBI opened at $149.78 on Friday. The stock has a fifty day moving average price of $158.35 and a two-hundred day moving average price of $146.89. The stock has a market capitalization of $10.04 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1 year low of $106.30 and a 1 year high of $169.89.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
